Predicted Cellular Immunity Population Coverage Gaps for SARS-CoV-2 Subunit Vaccines and Their Augmentation by Compact Peptide Sets.
Predicted Cellular Immunity Population Coverage Gaps for SARS-CoV-2 Subunit Vaccines and Their Augmentation by Compact Peptide Sets.
复制标题
DOI:
10.1016/j.cels.2020.11.010
复制
发表时间:
2021-01-20
期刊:
影响因子:
9.3
通讯作者:
Gifford DK
中科院分区:
文献类型:
--
作者:
Liu G;Carter B;Gifford DK
Subunit vaccines induce immunity to a pathogen by presenting a component of the pathogen and thus inherently limit the representation of pathogen peptides for cellular immunity-based memory. We find that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) subunit peptides may not be robustly displayed by the major histocompatibility complex (MHC) molecules in certain individuals. We introduce an augmentation strategy for subunit vaccines that adds a small number of SARS-CoV-2 peptides to a vaccine to improve the population coverage of pathogen peptide display. Our population coverage estimates integrate clinical data on peptide immunogenicity in convalescent COVID-19 patients and machine learning predictions. We evaluate the population coverage of 9 different subunits of SARS-CoV-2, including 5 functional domains and 4 full proteins, and augment each of them to fill a predicted coverage gap. Clinical data and machine learning predict SARS-CoV-2 peptide-HLA immunogenicity Human population coverage gaps of COVID-19 subunit vaccines are predicted Subunit augmentation improves vaccine population coverage for cellular immunity Subunit-free peptide vaccines are predicted to have high population coverage An integrated model of peptide-HLA immunogenicity based on data from COVID-19 patients and machine learning is used to evaluate and design COVID-19 vaccines for cellular immunity. Human population coverage gaps are predicted for COVID-19 subunit vaccines, and augmentation strategies are proposed to close these gaps. Compact peptide vaccine designs that do not include a subunit are presented that have good population coverage.
登录
查看更多内容
DOI:
10.4049/jimmunol.1700893
发表时间:
2017-11-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Jurtz V;Paul S;Andreatta M;Marcatili P;Peters B;Nielsen M
通讯作者:
Nielsen M
DOI:
10.1126/science.aam8825
发表时间:
2018-01-05
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Ramsuran V;Naranbhai V;Horowitz A;Qi Y;Martin MP;Yuki Y;Gao X;Walker-Sperling V;Del Prete GQ;Schneider DK;Lifson JD;Fellay J;Deeks SG;Martin JN;Goedert JJ;Wolinsky SM;Michael NL;Kirk GD;Buchbinder S;Haas D;Ndung'u T;Goulder P;Parham P;Walker BD;Carlson JM;Carrington M
通讯作者:
Carrington M
影响因子:
5.4
作者:
Avadhanula, V;Rodriguez, CA;Adderson, EE
通讯作者:
Adderson, EE
影响因子:
9.3
作者:
O'Donnell, Timothy J.;Rubinsteyn, Alex;Laserson, Uri
通讯作者:
Laserson, Uri
影响因子:
9.3
作者:
Liu, Ge;Carter, Brandon;Gifford, David K.
通讯作者:
Gifford, David K.